Reditux 100 mg is the trade name of a biosimilar version of rituximab, an anti-CD20 antibody used in the treatment of certain lymphomas, leukaemias and rheumatoid arthritis. Reditux is produced by Dr. Reddy's Laboratories, India's largest pharmaceutical company. It is a replacement for Mabthera ( Also known as Ristova in India )
Minimum Order Quantity: 1 Piece/Pieces
Port of Dispatch: Mumbai
Production Capacity: 1000-1500
Delivery Time: 7-10 days
Packaging Details: High quality packaging and storage facilities are used to store products.
Other Products in 'Anti Cancer Injections & Vial' category